Linked videos:
• Spironolactone for hai...
• What can women do to s...
• How to stop hair loss ...
• Will finasteride kill ...
Sources:
1. Wong IL, Morris RS, Chang L, Spahn MA, Stanczyk FZ, Lobo RA. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J Clin Endocrinol Metab. 1995;80(1):233-238. doi:10.1210/jcem.80.1.7829618
2. Moghetti P, Tosi F, Tosti A, et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2000;85(1):89-94. doi:10.1210/jcem.85.1.6245
3. Unger CA. Hormone therapy for transgender patients. Transl Androl Urol. 2016;5(6):877-884. doi:10.21037/tau.2016.09.04
4. Moreno-Arrones OM, Becerra A, Vano-Galvan S. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients. Clin Exp Dermatol. 2017;42(7):743-748. doi:10.1111/ced.13184
5. Leinung MC, Feustel PJ, Joseph J. Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health. 2018;3(1):74. doi:10.1089/trgh.2017.0035
6. Irwig MS. Is there a role for 5α-reductase inhibitors in transgender individuals? Andrology. 2021;9(6):1729-1731. doi:10.1111/andr.12881
7. Motosko CC, Tosti A. Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature. Dermatol Ther (Heidelb). 2021;11(5):1457-1468. doi:10.1007/s13555-021-00574-0
8. Gao JL, Streed CG, Thompson J, Dommasch ED, Peebles JK. Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics. Journal of the American Academy of Dermatology. 2023;89(4):774-783. doi:10.1016/j.jaad.2021.08.067
Негізгі бет Тәжірибелік нұсқаулар және стиль Is finasteride a transgender transition drug?
Пікірлер: 445